Related Experiment Video
Updated: May 14, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Alkaline phosphatase, serum phosphate, and incident cardiovascular disease and total mortality in older men
Sasiwarang Goya Wannamethee1, Naveed Sattar, Olia Papcosta
1Department of Primary Care and Population Health, University College London Medical School, Royal Free Campus, Rowland Hill St, London NW3 2PF, United Kingdom. g.wannamethee@ucl.ac.uk
Insights
Alkaline phosphatase (ALP) and serum phosphate are linked to increased total mortality in older men. While ALP predicts coronary heart disease risk, serum phosphate is associated with non-coronary cardiovascular disease mortality.
Area of Science:
- Biochemistry
- Cardiology
- Gerontology
Background:
- Cardiovascular disease (CVD) remains a leading cause of mortality in older adults.
- Serum phosphate and alkaline phosphatase (ALP) are common biomarkers, but their independent associations with CVD outcomes and mortality require further investigation.
- Understanding these associations can inform risk stratification and preventive strategies in elderly populations.
Purpose of the Study:
- To investigate the association between serum phosphate and alkaline phosphatase (ALP) levels and incident cardiovascular disease (CVD) outcomes.
- To examine the relationship between serum phosphate and ALP with total mortality in older men.
- To determine if these associations persist after adjusting for known CVD risk factors and excluding individuals with chronic kidney disease.
Main Methods:
- Prospective cohort study involving 3381 men aged 60-79 years without prior myocardial infarction or stroke.
- Follow-up averaged 11 years, during which major CVD events and total deaths were recorded.
- Statistical analyses included Cox proportional hazards models, adjusting for CVD risk factors, inflammation markers, and subgroup analyses excluding chronic kidney disease.
Main Results:
- Alkaline phosphatase (ALP), but not serum phosphate, was significantly associated with increased risk of coronary heart disease and overall CVD events.
- Serum phosphate showed an association with increased CVD mortality, specifically from non-coronary heart disease or stroke causes.
- Both elevated ALP and serum phosphate levels were independently associated with significantly increased total mortality in older men, even after comprehensive adjustments.
Conclusions:
- Alkaline phosphatase (ALP) is a significant predictor of coronary heart disease risk in elderly men.
- Serum phosphate is associated with specific CVD mortality pathways, distinct from coronary events.
- Both high ALP and serum phosphate levels represent important risk factors for all-cause mortality in older men, highlighting their clinical relevance.
Objective:
We have examined the association between serum phosphate and alkaline phosphatase (ALP) with incident cardiovascular disease (CVD) outcomes and total mortality in older men.
Approach And Results:
A prospective study of 3381 men, aged 60 to 79 years, without a history of myocardial infarction or stroke followed up for an average 11 years during which there were 605 major CVD events (fatal coronary heart disease and nonfatal myocardial infarction, stroke, and CVD death) and 984 total deaths. ALP but not serum phosphate was associated with increased risk of coronary heart disease and overall CVD events which persisted after adjustment for CVD risk factors and markers of inflammation and after exclusion of men with chronic kidney disease (adjusted hazard ratio per SD, 1.19 [1.05, 1.34]; P=0.007 and 1.10 [1.01, 1.21]; P=0.04). In contrast, serum phosphate was only associated with increased CVD mortality owing to noncoronary heart disease or stroke causes (adjusted hazard ratio per SD, 1.35 [1.01, 1.83]; P=0.04). Both raised phosphate and ALP were associated with significantly increased total mortality after full adjustment and exclusion of men with chronic kidney disease.
Conclusions:
ALP but not serum phosphate is associated with coronary heart disease risk in elderly men. High levels of ALP and serum phosphate are both associated with increased total mortality.
Related Concept Videos
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily regulated...
Introduction to Electrolytes
Role of Sodium
One...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...

